We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Sekisui Diagnostics

For 40 years SEKISUI Diagnostics has been committed to providing innovative medical diagnostics to physicians and lab... read more Featured Products: More products

Download Mobile App





Sekisui Diagnostics Displays Full Range of Clinical Chemistry, Point-of-Care, and Biochemical Solutions

By HospiMedica International staff writers
Posted on 19 Nov 2025

At MEDICA 2025, Sekisui Diagnostics is presenting a broad lineup of in-vitro diagnostic products spanning clinical chemistry reagents, point-of-care testing solutions, enzymes and specialty biochemicals, biopharmaceutical services, and blood collection tube raw materials. More...

Exhibiting in Hall 1, Stand D57, the company draws on more than 40 years of global diagnostics expertise to support physicians, hospitals, laboratories, and decentralized testing environments.

At the booth, visitors can explore the OSOM rapid-test family, which provides fast, lateral-flow diagnostics for a wide range of infectious diseases, including influenza, Group A Strep, and Trichomonas vaginalis. For clinical chemistry, Sekisui is also highlighting its SEKURE reagent kits, which offer liquid-stable technology, strong performance, proven reliability, and comprehensive support services. Calibrators, controls, and linearity materials are also on display to complement instrument-based testing.

Sekisui is also prominently featuring point-of-care and home-testing solutions at MEDICA 2025. The OSOM brand extends into home-use products, including antigen- and molecular-based kits for COVID-19 and other respiratory pathogens. Sekisui also introduces its Metrix molecular platform and the Acucy diagnostic reader, both designed to support instrument-enabled point-of-care workflows in decentralized settings.

High-quality enzymes and specialty biochemicals form another key part of the portfolio, with products tailored for a variety of applications, including pharmaceutical manufacturing, clinical chemistry reagents, and POC/biosensor devices. The company is also highlighting its raw materials for plastic vacuum blood-collection tubes and related pre-analytic systems, which are trusted by blood-collection tube manufacturers worldwide. Sekisui’s raw materials offer excellent performance characteristics that support stable, reliable serum generation with very low influence on clinical test results, contributing to more accurate diagnostics and improved patient outcomes.

Related Links:
Sekisui Diagnostics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Radiofrequency Generator
GX1
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A simple sensor placed on the infant’s forehead provides crucial information about cerebral blood flow and the amount of oxygen reaching the brain, as well as the amount that is extracted and consumed (Photo courtesy of Université de Montréal)

Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants

Premature birth, defined as delivery before 37 weeks of gestation, increases the risk of language, motor, and cognitive delays, yet many late preterm infants receive limited follow-up. Clinicians currently... Read more

Surgical Techniques

view channel
Image: Conceptual schematic of MEND in combination with eCPCs for laryngotracheal reconstruction (Gehret, P., Ali Akbari Ghavimi, S., Dumas, A.A. et al.Nature Communications (2026). DOI: 10.1038/s41467-026-73680-2)

Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing

Severe subglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. The condition can leave infants dependent on tracheostomy while awaiting reconstructive surgery to enable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.